Korro Bio Inc (KRRO)
Korro Bio stock today
Korro Bio closed at $14.31 on October 30, 2026, up 0.81% on the day. Over the past year it returned -60.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $206 million.
| Period | KRRO | S&P 500 (SPY) |
|---|---|---|
| 1 month | +44.5% | -0.9% |
| 3 months | +37.0% | +2.1% |
| Year to date | +78.7% | +11.7% |
| 1 year | -60.7% | +12.4% |
Key statistics
- Market value
- $206M
- Price / sales
- 86.5
- 52-week range
- $5.28 to $40.91
- Next report
- Nov 12, 2026 (estimated)
About Korro Bio
Korro Bio is a clinical-stage biopharmaceutical company developing cell and gene therapies.
Sector: Health Care
More on Korro Bio
- Financials: revenue, earnings and segmentsRevenue +181% in the year to Dec 2025
- Returns: what $1,000 became$1,000 one year ago is $392.73 today
No forecast, no recommendation. This page describes Korro Bio Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.